Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OrSense, a developer of monitors for non-invasive measurements of various blood parameters, has received a European CE Mark approval for its NBM-200MP, a multi-parameter sensor for non-invasive continuous hemoglobin, low signal oximetry and pulse rate measurements.
Subscribe to our email newsletter
According to OrSense, the NBM-200MP system offers for the first time a non-invasive, continuous and accurate measurement of oxygen saturation under all physiological conditions, as well as a unique, breakthrough non-invasive solution for accurate continuous and spot Hb measurements.
Lior Ma’ayan, CEO of OrSense, said: “We are excited about receiving the European CE approval for NBM-200MP. This is an important milestone for OrSense in the path for developing and marketing our unique non-invasive multi-parameter blood monitoring device, which is expected to enhance the quality of treatment and reduce operational costs in hospitals. Upon receiving the CE Mark, we will soon initiate sales in various countries in Europe.”